Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00194-2/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz--XUGj_xb2-rHmOfJnXWpImbbcaKMTCE5UkhRcSiXH2FiDmGVpxnmWFN-vbw7nI_a9iU-rkl7qHq6EFOJPYSgpNar53ZQ&_hsmi=332673160&utm_content=332651922&utm_source=hs_email